Willdan Group, Inc. (WLDN)

Sage Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 4, 2025	Dec 27, 2024	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021
Net Income	35.16	22.57	10.93	-8.45	-8.42	-14.5
Depreciation & Amortization	17.47	14.75	16.43	17.49	17.15	18.74
Loss (Gain) From Sale of Assets	-0.02	-0.02	-0.06	-0.06	-0.02	-0.02
Stock-Based Compensation	9.66	7.39	5.32	8.37	16.56	16.11
Provision & Write-off of Bad Debts	0.88	0.74	0.83	0.24	0.1	1.33
Other Operating Activities	-1	2.7	4.03	1.47	-0.41	2.5
Change in Accounts Receivable	-3.63	11.09	-21.13	-17.01	-11.07	38.57
Change in Accounts Payable	5.01	-0.83	4.36	-7.84	-4.7	7.37
Change in Unearned Revenue	1.73	8.37	0.6	-0.91	6.07	1.87
Change in Other Net Operating Assets	7.71	5.31	17.91	16.13	-5.46	-24.96
Operating Cash Flow	72.96	72.07	39.21	9.43	9.8	47.03
Operating Cash Flow Growth	51.55%	83.79%	315.71%	-3.78%	-79.15%	304.65%
Capital Expenditures	-8.81	-8.41	-9.93	-9.6	-8.5	-5.08
Sale of Property, Plant & Equipment	0.04	0.03	0.07	0.08	0.05	0.02
Cash Acquisitions	-42.5	-7.36	-1.6	-	-	-
Investing Cash Flow	-51.27	-15.74	-11.46	-9.53	-8.45	-5.06
Long-Term Debt Issued	-	-	105	21.72	2.07	25.14
Long-Term Debt Repaid	-	-9.76	-115.81	-15.97	-15.45	-42.75
Net Debt Issued (Repaid)	-36.01	-9.76	-10.81	5.74	-13.38	-17.61
Issuance of Common Stock	6.45	5.6	2.96	3.31	4.58	3.31
Repurchase of Common Stock	-3.72	-1.41	-0.21	-0.99	-3.12	-2.95
Other Financing Activities	-0.33	-	-15.79	0.3	-6.62	-1.76
Financing Cash Flow	-33.61	-5.57	-23.85	8.36	-18.53	-19.01
Net Cash Flow	-11.92	50.76	3.91	8.26	-17.18	22.95
Free Cash Flow	64.15	63.66	29.29	-0.17	1.3	41.95
Free Cash Flow Growth	60.97%	117.35%	-	-	-96.89%	741.67%
Free Cash Flow Margin	10.21%	11.25%	5.74%	-0.04%	0.37%	10.73%
Free Cash Flow Per Share	4.38	4.47	2.15	-0.01	0.10	3.56
Cash Interest Paid	7.45	7.52	10.19	5.07	3.54	5.03
Cash Income Tax Paid	3.24	1.32	-3.07	-1.12	-1.62	0.17
Levered Free Cash Flow	59.42	55.74	12.31	-10.44	8.22	41.86
Unlevered Free Cash Flow	64.23	60.62	18.2	-7.11	10.64	45.03
Change in Net Working Capital	-21.91	-27.3	7.43	18.96	9.14	-25.39

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q